HC Wainwright Cuts Kyverna Therapeutics (NASDAQ:KYTX) Price Target to $4.00
Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) had its price target reduced by analysts at HC Wainwright from $6.00 to $4.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. HC Wainwright’s price objective points to a potential upside of 102.02% from the stock’s current price. […]
Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) had its price target reduced by analysts at HC Wainwright from $6.00 to $4.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. HC Wainwright’s price objective points to a potential upside of 102.02% from the stock’s current price. […]
